Tango Therapeutics
(NASDAQ) TNGX
Tango Therapeutics Financials at a Glance
Market Cap
$3.32B
Revenue (TTM)
$62.38M
Net Income (TTM)
$101.59M
EPS (TTM)
$-0.86
P/E Ratio
-26.63
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$24.39
Volume
5,476
Open
$22.78
Price
$24.39
Volume
5,476
Open
$22.78
Previous Close
$23.02
Daily Range
$22.78 - $24.54
52-Week Range
$1.07 - $28.41
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$24.39
Volume
5,476
Open
$22.78
Previous Close
$23.02
Daily Range
$22.78 - $24.54
52-Week Range
$1.07 - $28.41
TNGX News
TNGX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Tango Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
137
CEO
Barbara L. Weber, MD
Website
www.tangotx.comHeadquarters
Boston, MA 02142, US
TNGX Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-37%
Return on Capital
-30%
Return on Assets
-25%
Earnings Yield
-3.76%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.32B
Shares Outstanding
144.24M
Volume
5.48K
Avg. Volume
3.35M
Financials (TTM)
Gross Profit
$60.10M
Operating Income
$111.29M
EBITDA
$109.01M
Operating Cash Flow
$138.89M
Capital Expenditure
$1.05M
Free Cash Flow
$139.93M
Cash & ST Invst.
$343.14M
Total Debt
$33.57M
Tango Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$479.00K
-111.6%
Gross Margin
0.00%
N/A
Market Cap
$3.32B
N/A
Market Cap/Employee
$21.42M
N/A
Employees
155
N/A
Net Income
$38.75M
-2.9%
EBITDA
$41.38M
-2.7%
Quarterly Fundamentals
Net Cash
$309.57M
+39.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$30.83M
-9.4%
Short Term Debt
$2.74M
+11.6%
Return on Assets
-25.48%
N/A
Return on Invested Capital
-29.52%
N/A
Free Cash Flow
$29.94M
+18.6%
Operating Cash Flow
$29.72M
+18.9%